Metabolon INC: services to measure metabolomics markers related to pancreatic cancer in human serum samples

Ended Purchase Order Awarded Last action

Contract number
HHSN261201500191P
Awardee
Awarding agency
Obligated
$146,900

Award facts

Opportunity
Contract value 100% obligated
$146,900.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27713, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · DE-obligation of funds from FY2015 expiring lines. -$100
Other Administrative Action 1 $0
Original award $147,000

About this award

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $146,900.04 to measure metabolomics markers related to pancreatic cancer in human serum samples, with an award date of July 5, 2015 and completion date of January 31, 2017. Work is performed in Durham, North Carolina. The purchase order represents a de-obligation of funds from an expiring FY2015 line and carries firm fixed-price terms with no set-aside designation.

Quick answers

Who was awarded contract HHSN261201500191P?

HHSN261201500191P was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on July 5, 2015.

How much is contract HHSN261201500191P worth?

The government has obligated $146,900 on HHSN261201500191P.

Was contract HHSN261201500191P competed?

The extent of competition for HHSN261201500191P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award